MIRM Mirum Pharmaceuticals Inc

USD 39.62 +0.19 ( +0.48%)
Icon

Mirum Pharmaceuticals Inc (MIRM) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 39.62

+0.19 (+0.48%)

N/A

0.51M

USD 64.00(+61.53%)

USD 22.00 (-44.47%)

Icon

MIRM

Mirum Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 39.62
+0.19 ( +0.48%)

Mirum Pharmaceuticals Inc (MIRM) Annual Income Statement (USD)

MIRM Quarterly Financials (USD)

Frequently Asked Questions About Mirum Pharmaceuticals Inc (MIRM) Stock

Mirum Pharmaceuticals Inc's (MIRM) last reported annual revenue was USD 186.37 Million.

Mirum Pharmaceuticals Inc's (MIRM) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

Mirum Pharmaceuticals Inc's(MIRM) is not profitable as of its last reported annual financials.

The net profit margin for Mirum Pharmaceuticals Inc's(MIRM) from its laster reported year is -87.68%

The return on equity (ROE) for Mirum Pharmaceuticals Inc's(MIRM) from its last reported annual financials is : N/A

The return on assets (ROA) for Mirum Pharmaceuticals Inc's(MIRM) from its last reported annual financials is : N/A

The return on invested capital (ROIC) for Mirum Pharmaceuticals Inc's(MIRM) from its last reported annual financials is : N/A

The Debt to Equity ratio for Mirum Pharmaceuticals Inc's(MIRM) from its last reported annual financials is : N/A

The dividend yield for Mirum Pharmaceuticals Inc's(MIRM) from its laster reported year is N/A

Mirum Pharmaceuticals Inc's(MIRM) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...